Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 1 of 2: GR values. - Dataset (ID:20364)

Filter results: >>>>
Cell line Drug name Experimental replicate Timepoint Drug concentration Live cell count Average live cell count, DMSO control Average live cell count (time = 0) Log10(drug concentration) GR value Relative cell count (treatment versus DMSO) Cell doublings (DMSO control) Experiment name
HCC1806 Alpelisib 2 72
1.0
11213.0 11894.0 1643.3
0.0
0.959 0.943 2.856
HCC1806 BYL719 0 2 72
HCC1806 Alpelisib 2 72
3.2
10596.3 11894.0 1643.3
0.505
0.921 0.891 2.856
HCC1806 BYL719 0 2 72
HCC1806 CAL-101 2 72
0.001
11230.8 11282.8 1643.3
-3.0
0.997 0.995 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
0.0032
11273.8 11282.8 1643.3
-2.49
0.999 0.999 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
0.01
11404.3 11282.8 1643.3
-2.0
1.010 1.010 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
0.032
11305.3 11282.8 1643.3
-1.49
1.000 1.000 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
0.1
11409.3 11282.8 1643.3
-1.0
1.010 1.010 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
0.32
11440.8 11282.8 1643.3
-0.495
1.010 1.010 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
1.0
11624.3 11282.8 1643.3
0.0
1.020 1.030 2.779
HCC1806 CAL101 0 2 72
HCC1806 CAL-101 2 72
3.2
11994.0 11282.8 1643.3
0.505
1.040 1.060 2.779
HCC1806 CAL101 0 2 72
HCC1806 Everolimus 2 72
0.001
10053.0 12020.5 1643.3
-3.0
0.879 0.836 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
0.0032
9348.8 12020.5 1643.3
-2.49
0.832 0.778 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
0.01
9417.5 12020.5 1643.3
-2.0
0.837 0.783 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
0.032
9329.3 12020.5 1643.3
-1.49
0.831 0.776 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
0.1
9054.3 12020.5 1643.3
-1.0
0.812 0.753 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
0.32
9042.0 12020.5 1643.3
-0.495
0.811 0.752 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
1.0
8742.8 12020.5 1643.3
0.0
0.790 0.727 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Everolimus 2 72
3.2
8863.5 12020.5 1643.3
0.505
0.799 0.737 2.871
HCC1806 Everolimus 0 2 72
HCC1806 Pictilisib 2 72
0.001
11432.3 11984.0 1643.3
-3.0
0.967 0.954 2.866
HCC1806 GDC0941 0 2 72
HCC1806 Pictilisib 2 72
0.0032
11408.5 11984.0 1643.3
-2.49
0.966 0.952 2.866
HCC1806 GDC0941 0 2 72
HCC1806 Pictilisib 2 72
0.01
11154.5 11984.0 1643.3
-2.0
0.951 0.931 2.866
HCC1806 GDC0941 0 2 72
HCC1806 Pictilisib 2 72
0.032
11917.8 11984.0 1643.3
-1.49
0.996 0.994 2.866
HCC1806 GDC0941 0 2 72
HCC1806 Pictilisib 2 72
0.1
11495.5 11984.0 1643.3
-1.0
0.971 0.959 2.866
HCC1806 GDC0941 0 2 72
HCC1806 Pictilisib 2 72
0.32
11380.8 11984.0 1643.3
-0.495
0.964 0.950 2.866
HCC1806 GDC0941 0 2 72
HCC1806 Pictilisib 2 72
1.0
10951.3 11984.0 1643.3
0.0
0.938 0.914 2.866
HCC1806 GDC0941 0 2 72